HRTX Adam Morgan buys $27.5M worth of shares
Aug 13, 2025, 4:35 AM
0.00%
What does HRTX do
Heron Therapeutics, based in San Diego, develops pharmaceutical products for acute care and oncology, including SUSTOL, CINVANTI, ZYNRELEF, and APONVIE, with 126 employees. Its products are distributed in the U.S.
Adam Morgan bought 1,836,558 shares of HRTX on 8 August at $15.00 per share, worth a total of $27.5M. They now own 8,753,290 HRTX shares, or a 27% holding increase.
📡️ Health Care
Insider Trades
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.